B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GRM6

MOLECULAR TARGET

glutamate metabotropic receptor 6

UniProt: O15303NCBI Gene: 29166 compounds

GRM6 (glutamate metabotropic receptor 6) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GRM6

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1eglumetad3.0420
2bdb whuutdbjxjrkmk2.208
3Glutamic Acid1.956
4Glutamic Acid1.956
5Miconazole0.691
6bdb 2 amino bicyclo 2 1 1 hexane 2 5 dicarboxylic acid abhxd i chembl905010.691

About GRM6 as a Drug Target

GRM6 (glutamate metabotropic receptor 6) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented GRM6 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GRM6 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.